Advertisement
UK markets close in 4 hours 20 minutes
  • FTSE 100

    8,139.92
    -6.94 (-0.09%)
     
  • FTSE 250

    20,125.42
    +5.06 (+0.03%)
     
  • AIM

    775.43
    -0.61 (-0.08%)
     
  • GBP/EUR

    1.1821
    -0.0024 (-0.20%)
     
  • GBP/USD

    1.2672
    -0.0014 (-0.11%)
     
  • Bitcoin GBP

    52,036.20
    -498.48 (-0.95%)
     
  • CMC Crypto 200

    1,365.45
    -22.71 (-1.64%)
     
  • S&P 500

    5,431.60
    -2.14 (-0.04%)
     
  • DOW

    38,589.16
    -57.94 (-0.15%)
     
  • CRUDE OIL

    78.32
    -0.13 (-0.17%)
     
  • GOLD FUTURES

    2,335.10
    -14.00 (-0.60%)
     
  • NIKKEI 225

    38,102.44
    -712.12 (-1.83%)
     
  • HANG SENG

    17,936.12
    -5.66 (-0.03%)
     
  • DAX

    18,009.26
    +7.24 (+0.04%)
     
  • CAC 40

    7,513.31
    +10.04 (+0.13%)
     

Monthly information on share capital and company voting rights

Cellectis Inc.
Cellectis Inc.

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, May 16, 2024 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

Date

Total number of shares
in the capital

Total number of voting rights

05/03/2024

99,955,535

87,891,239


For further information on Cellectis, please contact:

Media contact:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93, media@cellectis.com

Investor Relations contacts:
Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, investors@cellectis.com
Ashley R. Robinson, LifeSci Advisors, +1 617 430 7577

Attachment